PodcastIntel
Sign in Get Started Free
WSJ Events
WSJ Events

Revolution Medicines CEO on Defeating the RAS Gene

Oct 8, 2026 · 0:21:26
Listen to Episode
✨ AI Summary
  • Revolution Medicines CEO on ensuring access to cancer drug.
  • Pledges access for all eligible US patients.
  • Discusses breakthrough drug Rasonque and future plans.

Guests on This Episode

MG
Mark Goldsmith
Ph.D. Concordia University 2015 · 1 podcast appearance
›

More from WSJ Events

WSJ Events
Watch: CDC Director Erica Schwartz at Future of Health | WSJ
Oct 8, 2026 · 0:35:56
WSJ Events
Can AI Save Healthcare?
Oct 7, 2026 · 0:22:53
WSJ Events
Regeneron Co-Founder on R&D, Data and Omics
Oct 7, 2026 · 0:23:44
WSJ Events
Andreessen Horowitz's View of Healthcare Investing
Oct 7, 2026 · 0:19:13
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to WSJ Events and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →